MONDAY DEADLINE: Ardent Health, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action - RGRD Law

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and liability reserves, leading to significant financial losses for investors during the specified Class Period [1][3]. Group 1: Allegations Against Ardent Health - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which inflated reported financial positions [3]. - It is alleged that Ardent Health's accounts receivable framework allowed for delayed recognition of losses, contributing to misleading financial reporting [3]. - The company reportedly lacked sufficient professional malpractice liability insurance and reserves to cover claims, particularly in the New Mexico market, which has seen increasing social inflationary pressures [3]. Group 2: Financial Impact and Stock Performance - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised accounts receivable collectability assessments and a new revenue accounting system [4]. - The company also cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million – $615 million to $530 million – $555 million, citing persistent industry-wide cost pressures [4]. - Following these announcements, Ardent Health's stock price fell nearly 34%, reflecting the negative market reaction to the disclosed financial issues [4]. Group 3: Class Action Process - Investors who purchased Ardent Health securities during the Class Period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [5]. - The lead plaintiff has the authority to select a law firm for litigation and does not need to be the lead plaintiff to share in any potential recovery [5]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading firm in complex class action litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [6].